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Abstract 
Purpose:  
Renal tumor enucleation allows for maximal parenchymal preservation. Identifying 
pseudocapsule integrity is critically important in nephron sparing surgery by enucleation. Tumor 
invasion into and through capsule may have clinical implications although it is not routinely 
commented on in standard pathologic reporting. We sought to describe a system to standardize 
the varying degrees of pseudocapsule invasion and to identify predictors of invasion.   
 
Materials and Methods:  
A multicenter retrospective review was carried out between 2002-2014 at Indiana University 
Hospital (IUH) and Loyola University Medical Center (LUMC). 327 tumors were evaluated 
following removal via radical (RN), healthy margin partial (HM), or enucleation (EN) partial 
nephrectomy. Pathologists scored tumors using our invasion of pseudocapsule (i-Cap) scoring 
system. Multivariate analysis was performed to determine predictors of higher score tumors. 
 
Results:  
Tumor characteristics between surgical resection groups were similar. Enucleated tumors tended 
to have thinner pseudocapsule rims but did not demonstrate higher i-Cap scores. Rates of 
complete capsular invasion (i-Cap 3) were similar between surgical techniques and comprised 
22% of the overall cohort. Papillary histology along with increasing tumor grade was predictive 
of an i-Cap 3 score. 
 
Conclusions:  
A capsule invasion scoring system is useful in classifying renal cell carcinoma (RCC) 
pseudocapsule integrity. i-Cap scores appear independent of surgical technique. Complete 
capsular invasion is most common in papillary and high-grade tumors. Further work regarding 
the relevance of capsular invasion depth as it relates to oncological outcome in both local 
recurrence and disease specific survival is warranted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION: 
Partial nephrectomy (PN) remains the preferred surgical therapy for renal masses less than 7 
centimeters whenever feasible secondary to the well described benefits of nephron preservation 
and equivalent oncologic outcomes when compared to radical nephrectomy.1,2 Tumor 
enucleation (TE) is a nephron sparing surgical technique, commonly employed in patients with 
hereditary renal syndromes, which maximally preserves normal renal parenchyma.3 Recently, a 
tumor enucleation approach has become more prevalent in the surgical management of sporadic 
renal masses with promising initial results.4,5 
 
Renal tumor enucleation takes advantage of the renal tumor pseudocapsule, consisting of a 
fibrous band of compressed renal parenchyma that isolates the tumor from the surrounding 
healthy renal parenchyma and provides a natural dissection plane during surgery (Figure 1).6 
When compared to healthy margin partial nephrectomy for RCC, tumor enucleation has 
demonstrated comparable oncological outcomes in some series.7 Opponents of this technique 
caution that the integrity of the tumor pseudocapsule may predict the presence of a positive 
surgical margin. Although several publications have suggested that the presence of a positive 
margin does not predict tumor recurrence after partial nephrectomy, pathologic invasion of the 
tumor pseudocapsule may play an important role in predicting cancer recurrence and overall 
worse outcomes.8-12 Surgeons have recently purposely enucleated renal tumors at the base of the 
tumor/parenchymal interface, leading to a new standardization of surgical technique reporting.5 
 
Currently, there are no protocols for pathologists to use to characterize the integrity of the renal 
tumor pseudocapsule and the status of the pseudocapsule (presence, absence, invasion into) is 
not standardly reported to the treating urologist. In collaboration with the pathology and urology 
departments at our respective institutions, we sought to create a simple and easily reproducible 
scoring system (i-Cap) to assess the integrity of the renal tumor pseudocapsule and used this 
system to evaluate pathologic specimens treated over a 12-year period. In addition, we 
investigated the clinical parameters that may ultimately serve as pseudocapsule integrity 
predictors that may influence pre-surgical evaluation in an attempt to improve future patient 
outcomes. 
 
 
 
 
 
 
MATERIALS AND METHODS: 
Patient Selection: 
A multicenter retrospective cohort study was carried out at Indiana University Hospital (IUH) 
and Loyola University Medical Center (LUMC) from October 2002 – December 2014. Patients 
who underwent renal surgery with clear, papillary or chromophobe histologic subtypes were 
included in the study. Patients with clinical T1 staging preoperatively were included in this 
study, while higher staged, more aggressive tumors were excluded from this study. Patients with 
benign renal tumors such as oncocytoma and angiomyolipomas were excluded. Overall, 327 
patients who underwent radical (RN), healthy margin partial (HM) or enucleation (EN) partial 
nephrectomy were included.    
 
Pathologic Assessment: 
Trained genitourinary pathologists at each institution reviewed each pathological specimen. 
Tumors were staged according to the pTNM guidelines in the 7th edition of the American Joint 
Committee on Cancer (AJCC) Staging Manual and graded according to the criteria set out by the 
Fuhrman grade system.13,14 Tumor characteristics such as histologic subtype, mean 
pseudocapsule thickness, pseudocapsule completeness, presence and extent of pseudocapsular 
invasion, and surgical margin status were reviewed. Sections from the entire tumor-parenchymal 
interface were examined in all cases. 
 
Each tumor also received an i-Cap score between 1-3 in accordance with the designed 
pseudocapsular invasion (i-Cap) scoring system (Figure 2). i-Cap scores of 1 were assigned to 
tumors with completely intact pseudocapsule without cancerous invasion. i-Cap scores of 2 were 
assigned to tumors that either had focal absences within their pseudocapsule without invasion or 
cancerous tissue invasion partially into, yet not completely through the pseudocapsule. i-Cap 
scores of 3 were assigned to tumors that had completely lost pseudocapsule integrity where 
carcinoma extended into surrounding healthy parenchyma (Figure 2).  
 
Statistical Analysis: 
Clinical and demographic variables were compared across sites and by surgical techniques. Chi-
square tests, and fisher’s exact tests when appropriate, were used for categorical comparisons; 
while independent t-tests and one-way ANOVAs were used for continuous comparisons. 
Multivariable binary logistic regression was then performed to assess predictors of i-Cap 3 
tumors, versus i-Cap 1 and 2 tumors, via a stepwise selection procedure and AIC criterion. 
Statistical significance was assessed at an α=0.05 level and all analyses were conducted using 
SAS v9.4 (SAS Institute, Cary NC).     
 
RESULTS: 
A total of 327 patients participated in this study over the years of 2002-2014. Two hundred and 
four of these patients received care at Loyola University Medical Center while 123 patients 
received care at Indiana University Hospital. Baseline patient demographics and tumor 
characteristics are shown in Table 1. The median age was 55 years old (IQR 46-65). The 
majority of patients were male (213, 65.1%) and Caucasian (262, 80.1%) with a median BMI of 
29.8 kg/m2 (IQR 26-35.4).  
 
Radical, healthy margin, and enucleation partial nephrectomy were performed in 132, 151, and 
44 patients, respectively. The mean tumor size was 3.03 cm (SD 1.3 cm). Clear cell renal cell 
carcinoma was the most prevalent histology (208, 63.6%) while 90 (27.5%) tumors were 
papillary and 29 (8.9%) were chromophobe. The majority of patients had pT1a (267, 81.7%) and 
Fuhrman grade 2 (207, 64.7%) tumors on final pathology. Tumor characteristics varied between 
institutions in terms of both histology and stage (p<0.001). Tumors removed at Indiana 
University were more widely distributed in terms of histology while tumors removed at Loyola 
University were more commonly clear cell (148, 72.5% vs. 60, 48.8%). Those tumors removed 
at Indiana University were also more commonly staged pT1b when compared to that of the 
Loyola University population (33 (26.8%) vs. 21 (10.3%)).	  
	  
Invasion into the pseudocapsule (i-Cap) scores were assigned to all tumors included for analysis.  
i-Cap 1, 2 and 3 were assigned to 79 (24.2%), 176 (53.8%) and 72 (22%) tumors, respectively. i-
Cap scores were distributed evenly amongst surgical technique (p=0.09) except for i-Cap 3 
tumors which were less prevalent with tumor enucleation (16%) when compared to RN (25%) 
and HM (21%). Mean pseudocapsule thickness was 0.77 cm (SD 0.69). Pseudocapsule thickness 
was dependent on surgical technique as thinner pseudocapsules were observed in the enucleation 
group with mean pseudocapsule thickness in the radical nephrectomy group was 0.77, healthy 
margin 0.83, and enucleation partial nephrectomy 0.54 cm (p=0.047). Positive surgical margins 
were present overall in 11 (3.4%) cases. Ten of the 11 patients who had a positive surgical 
margin underwent healthy margin partial nephrectomy, while the remaining positive margin 
underwent radical nephrectomy. None of the patients who underwent tumor enucleation had a 
positive margin on pathologic analysis.  
 
Multivariate analysis was completed to investigate factors associated with renal tumors more 
likely to demonstrate a higher i-Cap score (complete invasion). Results are demonstrated in 
Table 3. Of note both surgical technique (radical nephrectomy vs healthy margin partial 
nephrectomy vs enucleation partial nephrectomy) and pseudocapsule thickness were not 
predictive of tumors having an i-Cap score of three. Tumor histology appeared to impact higher 
i-Cap 3 scores with papillary type renal cell carcinomas carrying the highest risk (OR 3.04, CI 
1.52-6.09, p=0.002). Increased risk of i-Cap 3 score was also seen in tumors with higher 
Fuhrman grade with grade 4 carrying the highest risk (OR 14.68, CI 2.16-123.18, p=0.007). i-
Cap 3 tumors were also more prevalent in the Loyola University population compared with the 
IU group (OR 2.26, CI 1.04-4.88, p=0.04). Patients with a higher BMI demonstrated modest 
increases in i-Cap scores when compared to smaller counterparts (OR 1.05, CI 1.01-1.10, 
p=0.01).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION: 
Nephron sparing surgery where technically feasible is the standard of care for clinical T1 renal 
masses.1 The literature has demonstrated the amount of parenchyma spared during these 
resections can directly correlate to improved long-term functional outcomes.15,16 In light of these 
observations, parenchymal function preservation has been pursued through means of focusing on 
either reduction in warm ischemic time or maximization of spared renal parenchyma tissue 
during extraction. Enucleation partial nephrectomy provides the opportunity to achieve both of 
these ends while producing oncological outcomes comparable to those achieved with healthy 
margin partial nephrectomy.7,17-20 Enucleation leverages the integrity of the pseudocapsule 
surrounding it in order to maintain negative surgical margin status.6,10-12 Our study was able 
characterize and classify the tumor pseudocapsule in T1 RCC by evaluating degrees of integrity 
and invasion in a previously operated set of patients. Additionally, we were able to determine 
that tumor grade and tumor histology may play a significant role in predicting a higher invasion 
(i-Cap) score. We hope that that this simple scoring system may be adopted, studied, and 
implemented by the evaluating pathologist when reporting to the managing urologist.  
 
Initially developed as an intervention for hereditary renal syndrome patients, tumor enucleation 
utilizes the pseudocapsular-parenchymal interface via blunt dissection along natural cleavage 
planes while sparing healthy surrounding parenchyma.3,21 The close border between tumor and 
healthy renal tissue manipulated during the enucleation creates concern regarding margin status 
and the potential for iatrogenic rupturing of the pseudocapsule during extraction, which may 
impact pathologic processing.22 Despite this, multiple studies done by Minervini et al. have 
demonstrated that even a relatively thin pseudocapsule successfully guards against iatrogenic 
increases in positive margin rates.11,12 Our data displayed positive surgical margin rates of 3.4% 
for all cases, with none occurring in the enucleation group. Despite the absence of increased 
margin rates, we observed the thinnest pseudocapsule in the enucleation group compared with 
other groups, suggesting that some degree of pseudocapsule may be altered when utilizing this 
technique. If tumor pseudocapsule invasion was principally a function of pseudocapsule 
thickness it may be assumed that the enucleation group would have the highest i-Cap scores. The 
opposite was true when analyzing our data with the lowest i Cap 3 rates found in the enucleation 
cohort. Whether this was a function of the technique or a byproduct of appropriate selection 
remains unknown. In any event it at least suggests that surgical technique –healthy margin versus 
enucleation partial nephrectomy— is not a critical predictor of capsule invasion and in it of itself 
should not dissuade surgeons from considering tumor enucleation as a viable option.  
 
The tumor pseudocapsule has been well described as a fibrous band of compressed renal 
parenchymal tissue encompassing most renal cell carcinoma. The integrity of the pseudocapsule 
may vary greatly depending on the histological features of the tumor it surrounds.11,23,24 Previous 
literature has demonstrated that tumor subtype may be predictive of pseudocapsule 
characteristics.11,12,24 Additionally, higher rates penetrating pseudocapsule disease in RCC may 
be seen in patients with of higher Fuhrman grade tumors and more advanced TNM stage.6,8-10,23 
In the current study, i-Cap scores of 1, 2 and 3 were assigned to 79 (24%), 176 (54%) and 72 
(22%) tumors, respectively amongst the entire cohort. Tumors scored as i-Cap 2 made up largest 
percentage of the cohort. i-Cap 3 scored tumors demonstrate complete loss of pseudocapsule 
integrity with penetration of tumor directly into surrounding parenchyma and carry the highest 
risk for loss of negative margin status. Although currently debated, early studies of the clinical 
implications of positive margins demonstrated a higher risk of tumor recurrence and should be 
avoided in all cases.25,26 Even when a positive margin never evolves into a clinically significant 
recurrence, the impact of rigorous surveillance may carry with it both a financial and emotion 
burden to the patient27,28 The i-Cap scoring system can provide an essential tool not only to the 
pathologist but also to the treating urologist to aid in the creation of an appropriate post-operative 
care plan for the renal cell cancer patient. 
 
Considering the importance of positive margins status and concurrent loss of pseudocapsule 
integrity, multivariate analysis was carried out during this study to investigate factors associated 
with i-Cap 3 tumors that may be preoperatively assessable through means of biopsy and imaging. 
In our analysis papillary type renal cell carcinomas carry the highest chances of i-Cap 3 scores 
compared to that of other histologic subtypes (OR 3.04, CI 1.52-6.09, p=0.002). Increasing risk 
of i-Cap 3 score was also observed in higher Fuhrman grade tumors with grade 4 carrying the 
highest risk (OR 14.68, CI 2.16-123.18, p=0.007). We believe this data implies that papillary 
histology and highly aggressive nuclear features observed on biopsy require special attention to 
margin status during the perioperative period. This study may also suggest that regardless of 
small tumor size, enucleation may not be clinically indicated in tumors exhibiting these 
histologic features. 
 
Creating a pseudocapsule scoring system that is easily implemented and interpreted is becoming 
increasingly important as interest in the consideration of enucleation partial nephrectomy in the 
sporadic solitary renal mass is expanding. Indeed, there is an effort to codify surgical approaches 
where enucleation is variably or partially employed in the surgical approach. A recent study 
conducted by Kutikov et al., the surface-intermediate-base (SIB) margin score was created as a 
means of commenting on the macroscopic remnant pseudocapsule surrounding the tumor.5 The 
authors attempted to validate the scoring system in a follow up analysis.29 The SIB scoring 
system provides is predicated on the surgeon’s ability to accurately assess the presence or 
absence of residual parenchyma around various sections of the removed renal tumor. The i-Cap 
scoring system, determined by histopathological analysis,  may function as an ideal complement 
to aforementioned SIB system in that it may provide a checks and balances to the surgeon’s 
assessment on a microscopic level. This could allow for improvement in the standardization of 
reporting and hopefully provide a valuable tool for tumor prognostication. Clearly, the ultimate 
utility and integration of both scoring systems for renal cell carcinoma have yet to be fully 
defined. 
 
The current study carries notable limitations. Pathologic scoring was done in a retrospective 
fashion after the initial pathologic review was already completed. Additionally, some i-Cap 
scores may have been upgraded secondary to iatrogenic disruption of the pseudocapsule during 
surgical removal and/or specimen processing. Inter-observer variation and institutional biases 
may have existed amongst pathologist grading the pseudocapsule integrity. Although the i-Cap 
scoring system is a quality tool to standardize the assessment of the renal tumor pseudocapsule, 
the clinical implication of this grading tool has yet to be defined and will require longer follow 
up. These limitations notwithstanding, this represents the first described attempt to classify the 
integrity of the tumor pseudocapsule through the creation of easy and simple reproducible 
scoring system for renal cell carcinoma.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION: 
Our study proposes a capsule invasion scoring system that may be useful in further classifying 
the tumor pseudocapsule integrity in small renal masses. Although tumor enucleation may 
attenuate the pseudocapsule, integrity of the capsule appears to be independent of surgical 
technique. Complete tumor pseudocapsule invasion into surrounding renal parenchyma appears 
most common in papillary histologic subtype and high-grade tumors. Further work regarding the 
implementation of the i-Cap scoring system and investigating the clinical implication of higher i-
Cap scores is warranted. 
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TABLES: 
Table	  1.	  Patient	  Population	  by	  Institution	  
Variables 
(%/Standard Deviation) 
Loyola 
University 
Medical Center 
N=204 
Indiana 
University 
Hospital 
N=123 
Total 
N=327 p-value 
Sex 
Male 
Female 
 
130 (63.7%) 
74 (36.3%) 
 
83 (67.5%) 
40 (32.5%) 
 
213 (65.1%) 
114 (34.9%) 
0.49 
Race 
White 
African American 
Hispanic 
Asian 
 
154 (75.5%) 
22 (10.8%) 
22 (10.8%) 
6 (2.9%) 
 
108 (87.8%) 
13 (10.6%) 
0 (0%) 
2 (1.6%) 
 
262 (80.1%) 
35 (10.7%) 
22 (6.7%) 
8 (2.4%) 
<0.001a 
Median Age (IQR) 54 (46-65) 57 (47.5-68.5) 55 (46-65) 0.10 
Median BMI (IQR) 30.8 (26.4-36.1) 28.2 (25.6-33.4) 29.8 (26.0-35.4) 0.01 
Surgical Technique 
Healthy Margin 
Radical 
Enucleation 
 
82 (40%) 
78 (38%) 
44 (22%) 
 
69 (56%) 
54 (44%) 
0 
151 (46.2%) 
132 (40.4%) 
44 (13.4%) 
<0.001 
Histologic Subtype 
Clear Cell 
Papillary 
Chromophobe 
 
148 (72.5%) 
43 (21.1%) 
13 (6.4%) 
 
60 (48.8%) 
47 (38.2%) 
16 (13.0%) 
 
208 (63.6%) 
90 (27.5%) 
29 (8.9%) 
<0.001 
Pathologic Stage 
T1a 
T1b 
T3a 
 
177 (86.8%) 
21 (10.3%) 
6 (2.9%) 
 
90 (73.2%) 
33 (26.8%) 
0 (0%) 
 
267 (81.7%) 
54 (16.5%) 
6 (1.8%) 
<0.001a 
Fuhrman Grade‡ 
1 
2 
3 
4 
 
17 (8.6%) 
124 (62.9%) 
48 (24.4%) 
8 (4.1%) 
 
4 (3.3%) 
83 (67.5%) 
35 (28.5%) 
1 (0.8%) 
 
21 (6.6%) 
207 (64.7%) 
83 (25.9%) 
9 (2.8%) 
0.08 
i-Cap Score 
1 
2 
3 
 
42 (20.6%) 
108 (52.9%) 
54 (26.5%) 
 
37 (30.1%) 
68 (55.3%) 
18 (14.6%) 
 
79 (24.2%) 
176 (53.8%) 
72 (22.0%) 
0.02 
Size (cm) 2.85 (1.17) 3.31 (1.54) 3.02 (1.3) 0.004 
Mean Pseudocapsule 
Thickness (cm) 
0.50 (0.44) 1.21 (0.80) 0.77 (0.69) <0.001 
Positive Surgical Margin 2 (1%) 9 (7.3%) 11 (3.4%) 0.003a 
Note: Chi-square test used for all categorical variables unless otherwise noted. Independent t-tests 
used for continuous variables. a. Fisher’s exact test used due to small expected cell counts 
‡ N=7 (3.4%) of LUMC tumors did not have a Fuhrman grade 
	  
Table	  2.	  Cohorts	  Examined	  by	  Surgical	  Technique	  
Variables 
(%/Standard Deviation) 
Healthy Margin 
N=151 
Radical 
N=132 
Enucleation 
N=44 p-value 
Histologic Subtype 
Clear Cell 
Papillary 
Chromophobe 
 
100 (66%) 
36 (24%) 
15 (10%) 
 
80 (61%) 
40 (30%) 
12 (9%) 
 
28 (64%) 
14 (32%) 
2 (5%) 
0.57 
Pathologic Stage 
T1a 
T1b 
T3a 
 
120 (79%) 
26 (17%) 
5 (3%) 
 
111 (84%) 
21 (16%) 
0 (0%) 
 
36 (82%) 
7 (16%) 
1 (2%) 
0.27a 
Fuhrman Grade 
N/A 
1 
2 
3 
4 
 
1 (0.5%) 
10 (7%) 
97 (64%) 
41 (27%) 
2 (1.5%) 
 
5 (3.8%) 
5 (3.8%) 
79 (60%) 
37 (28%) 
6 (4.4%) 
 
1 (2.5%) 
6 (14%) 
31 (70%) 
5 (11%) 
1 (2.5%) 
0.047a 
i-Cap Score 
1 
2 
3 
 
28 (19%) 
91 (60%) 
32 (21%) 
 
39 (30%) 
60 (45%) 
33 (25%) 
 
12 (27%) 
25 (57%) 
7 (16%) 
0.09 
Mean Size (cm)  2.94 (1.4) 3.12 (1.4) 3.02 (1.09) 0.53 
Mean Pseudocapsule 
Thickness (cm)  
0.83 (0.75) 0.77 (0.68) 0.54 (0.41) 0.047 
Positive Surgical Margin 10 (6.6%) 1 (0.8%) 0 (0%) 0.01a 
Note: Chi-square test used for all categorical variables unless otherwise noted. Independent t-
tests used for continuous variables. a. Fisher’s exact test used due to small expected cell counts 
	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table	  3.	  Clinical	  Predictors	  of	  Pseudocapsule	  Invasion	  (i-­‐Cap	  3)	  Analysis	  
Multivariable Analysis 
Odds Ratio (95% CI) p-value 
BMI 1.05 
 
(1.01-1.10) 0.01 
Site 
IUH 
LUMC 
 
 
REF 
2.26 
 
 
(1.04-4.88) 
0.04 
 
0.04 
Histologic Subtype 
Clear Cell 
Papillary  
Chromophobe 
 
REF 
3.04 
0.52 
 
 
(1.52-6.09) 
(0.12-2.23) 
0.01 
 
0.002 
0.38 
Pathologic Stage 
T1a 
T1b 
T3a 
 
REF 
0.45 
14.68 
 
 
(0.16-1.27) 
(1.51-143.09) 
0.02 
 
0.14 
0.02 
Fuhrman Grade 
1 
2 
3 
4 
 
REF 
1.50 
3.01 
16.33 
 
 
(0.39-5.76) 
(0.73-12.38) 
(2.16-123.18) 
0.008 
 
0.55 
0.13 
0.007 
	  
	  
	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURES: 
 
  
Figure 1. Microscopic Investigation: A) 5x Magnification B) 10x Magnification. 
Clear Cell Renal Cell Carcinoma with Intact Pseudocapsule: Inferior portion of figure 
exemplifies carcinoma isolated from superior portion of healthy parenchyma by pseudocapsule.  
KEY: Normal Kidney (NK), Pseudocapsule (PC), Renal Cell Carcinoma (RCC)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. i-Cap Scoring System. All pictures taken under 10x magnification. 
 KEY: Normal Kidney (NK), Pseudocapsule (PC), Renal Cell Carcinoma (RCC) 
